Effects of GLP-1 receptor agonists on gut microbiota: a systematic review
[16] While some participants in clinical studies have reported menstrual changes, these are generally attributed to the metabolic effects of weight loss rather than direct drug action on reproductive tissues, and are not classified as common adverse effects in the UK product information for GLP-1 medications
Gu J, Wang S, Guo H, Tan Y, Liang Y, Feng A, et al
Interest in this question has grown among women in perimenopause and menopause, when metabolism, appetite signals, and body composition begin to change
For many people struggling with weight, food represents a source of constant psychological conflict
Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort